Status:
COMPLETED
ANCHORS Study: UH2 Project
Lead Sponsor:
University of Florida
Collaborating Sponsors:
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Conditions:
HIV-1-infection
Eligibility:
MALE
18-35 years
Phase:
NA
Brief Summary
According to the National HIV/AIDS Strategy, men who have sex with men (MSM), young adults, Black and Latino men and people in the Southern U.S. are at highest HIV risk and should be targeted with cos...
Detailed Description
New prevention efforts must address alcohol and HIV and be directed to the highest-risk groups. While interventions have targeted MSM, few have targeted young MSM specifically. Young people and MSM br...
Eligibility Criteria
Inclusion
- Web-survey:
- Male sex
- Ages 18-30
- Ability to read and write English
- 1 or more instances of sexual activity with another man in the past 3 months
- HIV Negative
- Focus group:
- 18-35
- All other inclusion criteria will be the same as the web survey
- Usability phase:
- 5 or more drinks in a day in the past month
- Past-month intercourse with another man without a condom
- Willingness to try PrEP, but have never tried it before
Exclusion
- Web Screen:
- \- No subject may have lifetime use of PrEP
- Focus group:
- A current undergraduate or graduate student at any level in one of the 3 departments that make up the College of Health and Human Performance (HHP) at the University of Florida (UF), where Dr. Leeman's faculty appointment is.
- Do not want to engage in open discussion regarding substance use or sexual activity/orientation in a group setting. It will be possible for participants to contribute to focus group discussions without providing detailed information about their own substance use or sexual activity, however focus group participants must have a degree of openness to discussing these topics with others. These groups will take place with 6-7 other people and some people may be made uncomfortable by the discussions that may take place with regard to participants' drinking, substance use or sexual behavior.
- Not willing to be recorded via an electronic recording device
- Usability phase:
- No subject may have lifetime use of PrEP
- Those who do not wish to provide a reliable phone number will be excluded
Key Trial Info
Start Date :
December 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2023
Estimated Enrollment :
673 Patients enrolled
Trial Details
Trial ID
NCT03360422
Start Date
December 1 2017
End Date
July 1 2023
Last Update
July 11 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Florida
Gainesville, Florida, United States, 32611